M&T Bank Corp Repligen Corp Transaction History

M&T Bank Corp

$139 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Repligen Corp stock. As of the latest transaction made, M&T Bank Corp holds 3,166 shares of RGEN stock, worth $394,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,166

Previous 2,989 5.92%

Holding current value

$394,895

Previous $376,000 25.27%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$119.79 - $167.35 $21,202 - $29,620	177 Added 5.92%	3,166 $471,000
Q2 2024 Jul 31, 2024	SELL	$120.0 - $182.95 $3,480 - $5,305	-29 Reduced 0.96%	2,989 $376,000
Q1 2024 May 07, 2024	SELL	$170.78 - $208.42 $5,635 - $6,877	-33 Reduced 1.08%	3,018 $555,000
Q4 2023 Feb 06, 2024	BUY	$114.17 - $185.35 $3,767 - $6,116	33 Added 1.09%	3,051 $548,000
Q3 2023 Nov 02, 2023	SELL	$138.78 - $176.51 $6,383 - $8,119	-46 Reduced 1.5%	3,018 $479,000
Q2 2023 Aug 09, 2023	BUY	$138.42 - $180.31 $7,197 - $9,376	52 Added 1.73%	3,064 $433,000
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $423,906 - $544,378	-2,748 Reduced 47.71%	3,012 $507,000
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $800,080 - $1.09 Million	-4,926 Reduced 46.1%	5,760 $975,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $809,988 - $1.1 Million	4,987 Added 87.51%	10,686 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $2,085 - $3,330	13 Added 0.23%	5,699 $1.05 Million
Q2 2022 Aug 05, 2022	SELL	$140.68 - $188.02 $6,189 - $8,272	-44 Reduced 0.77%	5,686 $923,000
Q1 2022 May 09, 2022	SELL	$161.19 - $257.96 $5,319 - $8,512	-33 Reduced 0.57%	5,730 $1.08 Million
Q4 2021 Feb 07, 2022	BUY	$247.59 - $304.47 $2,475 - $3,044	10 Added 0.17%	5,763 $1.53 Million
Q3 2021 Oct 28, 2021	BUY	$194.77 - $324.21 $4,090 - $6,808	21 Added 0.37%	5,753 $1.66 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $14,928 - $19,885	-90 Reduced 1.55%	5,732 $1.15 Million
Q1 2021 May 06, 2021	SELL	$180.37 - $226.26 $118,863 - $149,105	-659 Reduced 10.17%	5,822 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $19,398 - $27,060	-131 Reduced 1.98%	6,481 $1.24 Million
Q3 2020 Nov 06, 2020	BUY	$122.51 - $158.27 $572,121 - $739,120	4,670 Added 240.47%	6,612 $976,000
Q2 2020 Jul 29, 2020	BUY	$94.33 - $140.48 $183,188 - $272,812	1,942 New	1,942 $240,000
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $198,600 - $247,466	-2,591 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$54.2 - $85.95 $140,432 - $222,696	2,591 New	2,591 $223,000

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.4M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account